Ghana’s long-standing reliance on imported vaccines is set to change fundamentally by 2027, driven by a technology transfer agreement between the National Vaccine Institute (NVI) and Indonesia’s state-owned vaccine manufacturer, PT Bio Farma. The partnership, which focuses on the production of tetanus diphtheria (Td) vaccine, marks Ghana’s first concrete step toward local manufacturing. If successful, … Continue reading How an Indonesian Partnership Could Begin Ghana’s Local Vaccine Production and End Import Dependence